OTC Markets OTCPK - Delayed Quote USD

Coloplast A/S (CLPBY)

Compare
10.92
-0.05
(-0.46%)
At close: January 14 at 3:58:39 PM EST
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
27,030,000.00
27,030,000.00
24,500,000.00
22,579,000.00
19,426,000.00
Cost of Revenue
8,761,000.00
8,761,000.00
8,172,000.00
7,050,000.00
6,113,000.00
Gross Profit
18,269,000.00
18,269,000.00
16,328,000.00
15,529,000.00
13,313,000.00
Operating Expense
10,983,000.00
10,983,000.00
9,483,000.00
8,619,000.00
6,958,000.00
Operating Income
7,286,000.00
7,286,000.00
6,845,000.00
6,910,000.00
6,355,000.00
Net Non Operating Interest Income Expense
-725,000.00
-725,000.00
-604,000.00
-197,000.00
-45,000.00
Pretax Income
6,395,000.00
6,395,000.00
6,025,000.00
6,127,000.00
6,233,000.00
Tax Provision
1,343,000.00
1,343,000.00
1,242,000.00
1,421,000.00
1,408,000.00
Net Income Common Stockholders
5,052,000.00
5,052,000.00
4,783,000.00
4,706,000.00
4,825,000.00
Diluted NI Available to Com Stockholders
5,052,000.00
5,052,000.00
4,783,000.00
4,706,000.00
4,825,000.00
Basic EPS
2.25
--
2.22
2.21
2.27
Diluted EPS
2.25
--
2.22
2.21
2.26
Basic Average Shares
2,249,000.00
--
2,154,000.00
2,125,000.00
2,128,000.00
Diluted Average Shares
2,249,000.00
--
2,155,000.00
2,128,000.00
2,132,000.00
Total Operating Income as Reported
7,320,000.00
7,320,000.00
6,771,000.00
6,439,000.00
6,155,000.00
Total Expenses
19,744,000.00
19,744,000.00
17,655,000.00
15,669,000.00
13,071,000.00
Net Income from Continuing & Discontinued Operation
5,052,000.00
5,052,000.00
4,783,000.00
4,706,000.00
4,825,000.00
Normalized Income
5,010,920.00
5,010,920.00
4,781,412.00
5,199,824.00
4,958,128.00
Interest Income
155,000.00
155,000.00
111,000.00
39,000.00
11,000.00
Interest Expense
795,000.00
795,000.00
638,000.00
172,000.00
25,000.00
Net Interest Income
-725,000.00
-725,000.00
-604,000.00
-197,000.00
-45,000.00
EBIT
7,190,000.00
7,190,000.00
6,663,000.00
6,299,000.00
6,258,000.00
EBITDA
8,480,000.00
8,480,000.00
7,732,000.00
7,229,000.00
7,050,000.00
Reconciled Cost of Revenue
8,761,000.00
8,761,000.00
8,172,000.00
7,050,000.00
6,113,000.00
Reconciled Depreciation
1,290,000.00
1,290,000.00
1,069,000.00
930,000.00
792,000.00
Net Income from Continuing Operation Net Minority Interest
5,052,000.00
5,052,000.00
4,783,000.00
4,706,000.00
4,825,000.00
Total Unusual Items Excluding Goodwill
52,000.00
52,000.00
2,000.00
-643,000.00
-172,000.00
Total Unusual Items
52,000.00
52,000.00
2,000.00
-643,000.00
-172,000.00
Normalized EBITDA
8,428,000.00
8,428,000.00
7,730,000.00
7,872,000.00
7,222,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
10,920.00
10,920.00
412.00
-149,176.00
-38,872.00
9/30/2021 - 1/13/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7716.T Nakanishi Inc.
2,508.00
+1.13%
 
5889.T JAPAN EYEWEAR HOLDINGS CO LTD
2,295.00
-0.04%
 
HOCPY HOYA Corporation
128.40
+0.61%
 
ISRG.MX Intuitive Surgical, Inc.
11,085.61
0.00%
 
SAUHY Straumann Holding AG
12.79
-1.39%
 
FIE.DE Fielmann Group AG
39.30
-0.25%
 
CZMWY Carl Zeiss Meditec AG
46.25
-2.55%
 
ESLOY EssilorLuxottica Société anonyme
119.97
+0.01%
 
STMN.SW Straumann Holding AG
118.75
+0.21%
 
BLCO Bausch + Lomb Corporation
17.24
-0.75%